

At April’s SupplySide East trade show, Sabinsa Corp. (East Windsor, NJ) explained how its branded Coleus forskohlii extract ingredient, ForsLean, is approachi...
Read More 
Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Proce...
Read More 
Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s ...
Read More 
Sabinsa Introduces Softgel Ready ForsLean® Soft Extracts Amid Exponential Growth In Coleus Demand: Company Cautions Against Low Quality Spam Knockoffs
Just in time for legitimate dietary supplement manufacturers to differentiate their products from the inferior spamtouted forskolin products driven by Dr. Oz an...
Read More 
Sabinsa Receives Payment from Creative Compounds for ForsLean® Trademark Infringement
An intellectual property battle lasting three years and reaching the US Supreme Court has ended at last with payment to Sabinsa Corporation by Creative Compound...
Read More 
Creative Compounds’ Attempt to Continue Trademark Infringement of Sabinsa’s ForsLean® Rejected by US Supreme Court
Sabinsa’s International Presence Sabinsa Corporation’s protracted battle against Creative Compounds’ trade mark infringement of Sabinsa’...
Read More 
Sabinsa Granted Forskolin Solubility Patent In China
Sabinsa’s International Presence The State Intellectual Property Office of the People’s Republic of China has granted Sabinsa a patent entitled: ...
Read More 
Sabinsa’s ForsLean® Gets PI Numbers From TGA To Enter Australian Market
Sabinsa Corporation has received Product Information (PI) numbers for ForsLean® 10% and 20% from Australia’s TGA (Therapeutic Goods Administration), a divisi...
Read More 
US Appeals Court Finds Creative Compounds Guilty of Trademark Infringement Against Sabinsa’s ForsLean®
Sabinsa’s International Presence Sabinsa Corporation has achieved a significant victory in protecting its intellectual property investment in ForsLean® w...
Read More 
Sabinsa Secures International Forskolin Patent: Granted In Republic of South Africa & Singapore
Sabinsa has been granted a patent in South Africa and Singapore as part of its PCT application on “Process of preparing water soluble diterpenes and their app...
Read More